DCDB n=54 | No DCDB n=138 | P value | |
Patients with current alcohol misuse | 63% (34) | 64% (88) | 0.917 |
Alcohol team review | 85% (29) | 66% (58) | 0.044 |
Thiamine prescribed | 91% (31) | 85% (75) | 0.552 |
Community alcohol plan | 62% (21) | 39% (34) | 0.026 |
Patients with HE-related admission | 30% (16) | 42% (58) | 0.138 |
Lactulose prescribed | 94% (15) | 91% (53) | 1.0 |
Rifaximin prescribed | 94% (15) | 84% (49) | 0.679 |
Patients with ascites | 70% (38) | 69% (95) | 0.886 |
Discharge creatinine documented in discharge summary | 66% (25) | 6% (6) | <0.001 |
Documented plan for electrolyte monitoring in community | 61% (23) | 36% (34) | 0.012 |
Patients presenting with variceal bleed | 15% (8) | 11% (15) | 0.464 |
Treated with beta-blockers, and/or repeat gastroscopy booked or TIPSS | 100% (8) | 89% (13) | 0.526 |
Readmission within 30 days | 31% (17) | 25% (35) | 0.470 |
Potentially preventable liver related 30-day readmission | 4% (2) | 7% (10) | 0.407 |
DCDB, decompensated cirrhosis discharge bundle; HE, hepatic encephalopathy; TIPSS, transcutaneous intrahepatic portosystemic shunt.